Item 8.01 Other Events. On May 28, 2026, Soligenix, Inc. (the “Company”) filed a prospectus supplement (the “Current Prospectus Supplement”) to increase the maximum aggregate offering amount of the shares of the Company’s common stock, par value $0.001 per share, issuable under the At Market Issuance Sales Agreement dated January 23, 2026 (the “Sales Agreement”) with Rodman & Renshaw LLC, by an additional aggregate amount of $2,956,000. The Company previously sold approximately $3,445,000 of shares of common stock pursuant to the Sales Agreement under a prior prospectus supplement. A copy of the legal opinion as to the legality of the $2,956,000 of shares of common stock issuable under the Sales Agreement and covered by the Current Prospectus Supplement is filed as Exhibit 5.1 attached hereto.
SNGX Soligenix, Inc. - 8-K
Accession
0001104659-26-0676498.019.01
Item 8.01 - Other Events
126 words
Item 9.01 - Financial Statements and Exhibits
53 words
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 5.1 Opinion of Duane Morris LLP 23.1 Consent of Duane Morris LLP 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 2